Reopening America

Moderna Data Shows Its Vaccine Is Safe and Produces Antibodies in Children Ages 6-11

Falling in line with what we heard from Pfizer’s mRNA vaccine, Moderna has released interim data showing that their vaccine is also safe and produced the desired immune response in children ages 6-11. The dosage would be half of what it is for adults, but still come in a 2-shot protocol. Peter Loftus, pharmaceutical reporter at the WSJ, joins us for what to expect as the vaccines get closer to being approved for children. Learn more about your ad-choices at <a href="https://www.iheartpodcastnetwork.com">https://www.iheartpodcastnetwork.com</a>See <a href="https://omnystudio.com/listener">omnystudio.com/listener</a> for privacy information.

We have shifted into a new phase in the coronavirus pandemic. We are social distancing, washing our hands, wearing face masks, and we are Reopening America. Oscar Ramirez from the Daily Dive Podcast updates you on any new information about the virus and vaccine development, but will focus on how cities, states, and industries affected by the shutdown are opening back up.